Intensive surveillance over unfair patient allurement

Published: 2001-07-31 06:59:00

Updated: 2001-07-31 06:59:00

The Seoul district FDA has a plan to keep an intensive watching over unfair trade practices in the field including a business collusion between pharmacies and medical institutes and unreasonable patient allurement.

The district SFDA invited 24 Seoul district KPA representatives to a confab on...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK